A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience
Megan Jean McKee(University of North Carolina at Chapel Hill), Timothy M. Zagar(University of North Carolina at Chapel Hill), Elizabeth Claire Dees(University of North Carolina at Chapel Hill), Rebecca L. Green(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Allison M. Deal(Memorial Sloan Kettering Cancer Center), Matthew G. Ewend, Kevin Keith(Medical University of South Carolina), Julie M. Benbow(University of North Carolina at Chapel Hill), Amy Wheless(University of North Carolina at Chapel Hill), Amy Garrett(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University)
Cited by 34
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k